22 - CLAP

11.8 BIBLIOGRAFÍA RECOMENDADAGentamicina1588. Agarwal G, Rastogi A, Pyati S,Wilks A, Pildes RS. Comparison of once-daily versus twice-daily gentamicindosing regimens in infants > or = 2500 g. J Perinatol. 2002 Jun;22(4):268-74.1589. Aust G, Schneider D. Vestibular toxicity of gentamycin in newborn infants. Laryngorhinootologie. 2001Apr;80(4):173-6.1590. Avent ML, Kinney JS, Istre GR, Whitfield JM. Gentamicin and tobramycin in neonates: comparison ofa new extended dosing interval regimen with a traditional multiple daily dosing regimen. Am J Perinatol.2002 Nov;19(8):413-20.1591. Chattopadhyay B. Newborns and gentamicin—how much and how often? J Antimicrob Chemother.2002 Jan;49(1):13-6.1592. Chotigeat U, Narongsanti A, Ayudhya DP. Gentamicin in neonatal infection: once versus twice dailydosage. J Med Assoc Thai. 2001 Aug;84(8):1109-15.1593. de Hoog M, Mouton JW, van den Anker JN.Thoughts on Population pharmacokinetics and relationshipbetween demographic and clinical variables and pharmacokinetics of gentamicin in neonates.Ther DrugMonit. 2003 Apr;25(2):256-7; author reply 257.1594. DiCenzo R, Forrest A, Slish JC, Cole C, Guillet R. A gentamicin pharmacokinetic population model andonce-daily dosing algorithm for neonates. Pharmacotherapy. 2003 May;23(5):585-91.1595. Giapros VI, Andronikou SK, Cholevas VI, Papadopoulou ZL. Renal function and effect of aminoglycosidetherapy during the first ten days of life. Pediatr Nephrol. 2003 Jan;18(1):46-52. Epub 2002 Nov 15.1596. Glover ML, Shaffer CL, Rubino CM, Cuthrell C, Schoening S, Cole E, Potter D, Ransom JL, Gal P. Amulticenter evaluation of gentamicin therapy in the neonatal intensive care unit. Pharmacotherapy.2001 Jan;21(1):7-10.1597. Gooding N, Elias-Jones A, Shenoy M. Gentamicin dosing in neonatal patients. Pharm World Sci. 2001Oct;23(5):179-80.1598. Kaminska E, Piekarczyk A, Prokopczyk J, Zimak J, Sosnowska K, Taljanski W. Pharmacokinetic andtherapeutic monitoring of gentamicin serum concentration in neonates. Med Wieku Rozwoj. 2001 Apr-Jun;5(2):141-7.1599. Itsarayoungyuen S, Riff L, Schauf V, Hamilton L, Otrembiak J,Vidyasagar D. Tobramycin and gentamicinare equally safe for neonates: results of a double-blind randomized trial with quantitative assessmentof renal function. Pediatr Pharmacol (New York). 1982;2(2):143-55.1600. McCracken GH Jr, Freij BJ. Clinical pharmacology of antimicrobial agents. In Infectious Diseases of theFetus and Newborn Infant 3rd Ed. Remington Js and Klein JO Eds.WB Saunders, Philadelphia 1990, pp1053-1055.1601. Miron D, Steinfeld M, Hasanein J, Felszer C, Reich D. Tolerability of once-daily-dosing of intravenousgentamicin in preterm neonates born at 32-37 weeks of gestation. Harefuah. 2003Jun;142(6):413-5, 487.1602. Noerr B. Gentamicin dosing recommendations. Neonatal Netw. 2000 Jun;19(4):81-6.1603. Rastogi A, Agarwal G, Pyati S, Pildes RS. Comparison of two gentamicin dosing schedules in very lowbirth weight infants. Pediatr Infect Dis J. 2002 Mar;21(3):234-40.1604. Regev RH, Litmanowitz I, Arnon S, Shiff J, Dolfin T. Gentamicin serum concentrations in neonates bornto gentamicin-treated mothers. Pediatr Infect Dis J. 2000 Sep;19(9):890-1.1605. Rocha MJ, Almeida AM, Afonso E, Martins V, Santos J, Leitao F, Falcao AC. The kinetic profile ofgentamicin in premature neonates. J Pharm Pharmacol. 2000 Sep;52(9):1091-7.1606. Stickland MD, Kirkpatrick CM, Begg EJ, Duffull SB, Oddie SJ, Darlow BA. An extended intervaldosing method for gentamicin in neonates. J Antimicrob Chemother. 2001 Dec;48(6):887-93.MANUAL CLÍNICO AIEPI NEONATAL 222